ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Creative Medical Technology (CELZ)
Creative Medical Technology stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$0.69▼ -2.46%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
45%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Creative Medical Technology in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Creative Medical Technology
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Creative Medical Technology a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $0.58 and $0.78; in 9 out of 10, between $0.44 and $1.02. Estimated annual volatility is 87%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $6.25
- 52-week low
- $0.62
- Revenue (12 months)
- $0.0M
- Revenue growth (YoY)
- -45.5%
- Gross margin
- 63.4%
- Return on equity
- -77.9%
- Free cash flow (12 months)
- $-3.5M
- Beta
- 2.04
What this means
ATLAS does not publish a fair value for CELZ right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks CELZ has traded between $0.62 and $6.25. Today it is 88.9% below that high and 11% above its low.
Its beta is 2.04: it tends to move more than the market, both up and down.
About the company
Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company focused on regenerative medicine and novel biological therapeutics.
Want to see everything about Creative Medical Technology?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Creative Medical Technology do?
Creative Medical Technology Holdings, Inc. is a commercial-stage biotechnology company focused on regenerative medicine and novel biological therapeutics.
What is the chance CELZ goes up next month?
45%: close to a coin flip. In half of the simulated outcomes, CELZ ends the month between $0.58 and $0.78.
How volatile is CELZ?
ATLAS estimates annual volatility at 87%. In a typical month, half of the outcomes end between $0.58 and $0.78.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer